Role of Vitamin D in Autism
Abstract: Autism is characterized by abnormal immunology, altered oxidative stress and even genetic ab-normality in addition to behavioral problems. Vitamin D deficiency is ubiquity in children with autism. Vitamin D plays a role in regulating immune, up-regulating glutathione, and controlling genome in addition to traditional action on calcium and phosphate regulation. We recently reported that vitamin D supplementation could improve the behavioral manifestations in autistic child, which illustrated that vitamin D was involved in the pathogenesis of autism. Herein we summarize the research progress of the role of vitamin D in autism.
文章引用: 贾飞勇 , 单 玲 , 冯俊燕 , 王 冰 , 李洪华 , 杜 琳 (2014) 维生素D在自闭症中作用的研究进展。 国际神经精神科学杂志， 3， 21-27. doi: 10.12677/IJPN.2014.34004
 李洪华, 姜慧轶, 杜琳, 等 (2012) 儿童孤独症的早期筛查与诊断研究进展. 中国实验诊断学, 11, 2147-2150.
 Malik, M., Sheikh, A.M., Wen, G., et al. (2011) Expression of inflammatory cytokines, Bcl2 and ca-thepsin D are altered in lymphoblasts of autistic subjects. Immunobiology, 216, 80-85.
 Cabanlit, M., Wills, S., Goines, P., et al. (2007) Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder. Annals of the New York Academy of Sciences, 1107, 92-103.
 Rossignol, D.A., Rossignol, L.W., James, S.J., et al. (2007) The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: an open-label pilot study. BMC Pediatrics, 7, 36.
 Ronemus, M., Iossifov, I., Levy, D., et al. (2014) The role of de novo mutations in the genetics of autism spectrum disorders. Nature Reviews Genetics, 15, 133-141.
 段小燕，贾飞勇，姜慧轶 (2013) 维生素D与孤独症谱系障碍的关系. 中国当代儿科杂志, 15, 698-702
 贾飞勇, 王冰, 单玲, 等（2014）维生素D改善孤独症谱系障碍患儿行为. 亚洲儿科病例研究, 2, 21-24.
 Lu, Z., Chen, T.C., Zhang, A., et al. (2007) An evaluation of the vitamin D3 content in fish: Is the vitamin D content adequate to satisfy the dietary requirement for vitamin D? The Journal of Steroid Biochemistry and Molecular Biology, 103, 642-644.
 Cannell, J.J., Hollis, B.W., Zasloff, M., et al. (2008) Diagnosis and treatment of vitamin D deficiency. Expert Opinion on Pharmacotherapy, 9, 107-118.
 Eyles, D.W., Burne, T.H. and McGrath, J.J. (2013) Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Frontiers in Neuroendocrinology, 34, 47-64.
 Guillot, X., Semerano, L., Saidenberg-Kermanach, N., Fal-garone, G. and Boissier, M.-C. (2010) Vitamin D and inflammation. Joint Bone Spine, 77, 552-557.
 Baeke, F., Takiishi, T., Korf, H., Gysemans, C. and Mathieu, C. (2010) Vitamin D: Modulator of the immune system. Current Opinion in Pharmacology, 10, 482-496.
 Cohly, H.H. and Panja, A. (2005) Immunological findings in autism. In-ternational Review of Neurobiology, 71, 317- 341.
 Gao, D., Trayhurn, P. and Bing, C. (2012) 1,25-Dihydroxyvitamin D(3) inhibits the cytokine-induced secretion of MCP-1 and reduces monocyte recruitment by human preadipocytes. International Journal of Obesity, 37, 356-365.
 Shedeed, S.A. (2012) Vitamin D supple-mentation in infants with chronic congestive heart failure. Pediatric Cardiology, 33, 713-719.
 Tamiji, J. and Crawford, D.A. (2010) The neurobiology of lipid metabolism in autism spectrum disorders. Neurosignals, 18, 98-112.
 Ziats, M.N. and Rennert, O.M. (2011) Expression profiling of autism candidate genes during human brain development implicates central immune signaling pathways. PLoS ONE, 6, e24691.
 Rout, U.K., Mungan, N.K. and Dhossche, D.M. (2012) Presence of GAD65 autoantibodies in the serum of children with autism or ADHD. European Child & Adolescent Psychiatry, 21, 141-147.
 Goines, P., Haapanen, L., Boyce, R., Duncanson, P., Braunschweig, D., Delwiche, L., et al. (2011) Autoantibodies to cerebellum in children with autism associate with behavior. Brain, Behavior, and Immunity, 25, 514-523.
 Munoz, L.E., Schiller, M., Zhao, Y., Voll, R.E., Schett, G. and Herrmann, M. (2012) Do low vitamin D levels cause problems of waste removal in patients with SLE? Rheumatology, 51, 585-587.
 Hayes, C.E., Nashold, F.E., Spach, K.M. and Pedersen, L.B. (2003) The immunological functions of the vitamin D endocrine system. Cellular and Molecular Biology, 49, 277-300.
 Adorini, L. and Penna, G. (2008) Control of autoimmune diseases by the vitamin D endocrine system. Nature Clinical Practice Rheumatology, 4, 404-412.
 Mostafa, G.A. and Al-Ayadhi, L.Y. (2012) Reduced serum concentrations of 25-hydroxy vitamin D in children with autism: Relation to autoimmunity. Journal of Neuroinflammation, 9, 201.
 Dimeloe, S., Nanzer, A., Ryanna, K. and Hawrylowicz, C. (2010) Regulatory T cells, inflammation and the allergic response: The role of glucocorticoids and Vitamin D. The Journal of Steroid Biochemistry and Molecular Biology, 120, 86-95.
 Toubi, E. and Shoenfeld, Y. (2010) The role of vitamin D in regulating immune responses. Israel Medical Association Journal, 12, 174-175.
 Mostafa, G.A., Al Shehab, A. and Fouad, N.R. (2010) Frequency of CD4+CD25high regulatory T cells in the peripheral blood of Egyptian children with autism. Journal of Child Neurology, 25, 328-335.
 Prietl, B., Pilz, S., Wolf, M., Tomaschitz, A., Obermayer-Pietsch, B., Graninger, W. and Pieber, T.R. (2010) Vitamin D supplementation and regulatory T cells in apparently healthy subjects: Vitamin D treatment for autoimmune diseases? Israel Medical Association Journal, 12, 136-139.
 James, S.J., Cutler, P., Melnyk, S., Jernigan, S., Janak, L., Gaylor, D.W. and Neubrander, J.A. (2004) Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. The American Journal of Clinical Nutrition, 80, 161l-1617.
 Garcion, E., Thanh, X.D., Bled, F., Teissier, E., Dehouck, M.P., Rigault, F., et al. (1996) 1,25-Dihydroxyvitamin D3 regulates gamma 1 transpeptidase activity in rat brain. Neuroscience Letters, 216, 183-186.
 Lin, A.M., Chen, K.B. and Chao, P.L. (2005) Antioxidative effect of vitamin D3 on zinc-induced oxidative stress in CNS. Annals of the New York Academy of Sciences, 1053, 319-329.
 Halicka, H.D., Zhao, H., Li, J., Traganos, F., Studzinski, G.P. and Darzynkiewicz, Z. (2012) Attenuation of constitutive DNA damage signaling by 1,25-dihydroxyvitamin D3. Aging, 4, 270-278.
 Cannell, J.J. (2008) Autism and vitamin D. Medical Hypotheses, 70, 750-759.
 Cannell, J.J. and Grant, W.B. (2013) What is the role of vitamin D in autism? Dermato-Endocrinology, 5, 199-204.
 Schnatz, P.F., Nudy, M.O., Sullivan, D.M., Jiang, X., Cline, J.M., Kaplan, J.R., et al. (2012) The quantification of vitamin D receptors in coronary arteries and their association with atherosclerosis. Maturitas, 73, 143-147.
 Levin, G.P., Robinson-Cohen, C., de Boer, I.H., Houston, D.K., Lohman, K., Liu, Y., et al. (2012) Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. Journal of the American Medical Association, 308, 1898-1905.
 Karohl, C., Su, S., Kumari, M., Tangpricha, V., Veledar, E., Vaccarino, V. and Raggi, P. (2010) Heritability and seasonal variability of vitamin D concentrations in male twins. The American Journal of Clinical Nutrition, 92, 1393- 1398.
 Mostafa, G.A. and Al-Ayadhi, L.Y. (2013) Reduced serum concentrations of 25-hydroxy vitamin D in children with autism: Relation to autoimmunity. Journal of Neuroinflammation, 9, 201.
 Wang, T.J., Zhang, F., Richards, J.B., Kestenbaum, B., van Meurs, J.B., Berry, D., et al. (2010) Common genetic determinants of vitamin D insufficiency: A genome-wide association study. The Lancet, 376, 180-188.
 Meguid, N.A., Hashish, A.F., Anwar, M. and Sidhom, G. (2010) Reduced serum levels of 25-hydroxy and 1,25-dihy- droxy vitamin D in Egyptian children with autism. Journal of Alternative and Complementary Medicine, 16, 641-645.
 Grant, W.B. and Cannell, J.J. (2013) Autism prevalence in the United States with respect to solar ultraviolet-B doses: An ecological study. Dermato-Endocrinology, 5, 9-14.
 Neale, B.M., Kou, Y., Liu, L., Ma’ayan, A., Samocha, K.E., Sabo, A., et al. (2012) Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature, 485, 242-245.
 Fleet, J.C., De Smet, M., Johnson, R. and Li, Y. (2012) Vitamin D and cancer: A review of molecular mechanisms. Biochemical Journal, 441, 61-76.
 Haliska, H.D., Zhao, H., Li, J., Traganos, F., Studzinski, G.P. and Darzynkiewicz, Z. (2012) Attenuation of constitutive DNA damage signaling by 1,25-dihydroxyvitamin D3. Aging, 4, 270-278.
 Ting, H.J., Yasmin-Karim, S., Yan, S.J., Hsu, J.W., Lin, T.H., Zeng, W., et al. (2012) A positive feedback signaling loop between ATM and the vitamin D receptor is critical for cancer chemoprevention by vitamin D. Cancer Research, 72, 958-968.
 Fedirko, V., Bostick, R.M., Long, Q., Flanders, W.D., McCullough, M.L., Sidelnikov, E., et al. (2010) Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: A randomized clinical trial. Cancer Epidemiology, Biomarkers & Prevention, 19, 280-291.
 Smith, D.C., Johnson, C.S., Freeman, C.C., Muindi, J., Wilson, J.W. and Trump, D.L. (1999) A phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy. Clinical Cancer Research, 5, 1339-1345.
 Fedirko, V., Bostick, R.M., Flanders, W.D., Long, Q., Shaukat, A., Rutherford, R.E., et al. (2009) Effects of vitamin D and calcium supplementation on markers of apoptosis in normal colon mucosa: A randomized, double-blind, placebo-controlled clinical trial. Cancer Prevention Research, 2, 213-223.